Publications by authors named "Tihui Fu"

Claim this Profile
B
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
Lewis Zhichang Shi, Sangeeta Goswami, Tihui Fu, Baoxiang Guan, Jianfeng Chen

Cancer Immunol Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.
Yared Hailemichael, Amber Woods, Tihui Fu, Qiuming He, Michael C Nielsen

J Clin Invest· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy.
Lewis Zhichang Shi, Tihui Fu, Baoxiang Guan, Jianfeng Chen, Jorge M Blando

Nat Commun· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Todd C Metzger, Hua Long, Shobha Potluri, Thomas Pertel, Samantha L Bailey-Bucktrout, Tihui Fu

Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy.
Hong Chen, Tihui Fu, Woong-Kyung Suh, Dimitra Tsavachidou, Sijin Wen

Cancer Immunol Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide.
Jingjing Sun, Derek Ng Tang, Tihui Fu, Padmanee Sharma

Cancer Discov· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.
Tihui Fu, Qiuming He, Padmanee Sharma

Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3.
Kang Li, Yucheng Li, Wenjuan Wu, Wendy R Gordon, David W Chang, Tihui Fu

J Biol Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.
Guangyong Peng, Zhong Guo, Yukiko Kiniwa, Kui Shin Voo, Weiyi Peng, Tihui Fu, Rong-Fu Wang

Science· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation.
Kui Shin Voo, Guangyong Peng, Zhong Guo, Tihui Fu, Yanchun Li, Rong-Fu Wang

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique mucin immunoenhancing peptide with antitumor properties.
Lynn M Herbert, Joseph F Grosso, Mantley Dorsey, Tihui Fu, Iafa Keydar

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.
Tihui Fu, Kui Shin Voo, Rong-Fu Wang

J Clin Invest· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
Kui Shin Voo, Tihui Fu, Helen Y Wang, Judy Tellam, Helen E Heslop, Rong-Fu Wang

J Exp Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.
Kui Shin Voo, Tihui Fu, Helen E Heslop, Malcolm K Brenner, Cliona M Rooney, Rong-Fu Wang

Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells.
Helen Y Wang, Tihui Fu, Gang Wang, Gang Zeng, Donna M Perry-Lalley, Rong-Fu Wang

J Clin Invest· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis